Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Amneal Pharmaceuticals, Inc.
IPO Date: January 1, 1900
Sector: Healthcare
Industry: Biotech
Market Cap: $2.64B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.15 | 2.51%
Avg Daily Range (30 D): $0.11 | 1.40%
Avg Daily Range (90 D): $0.13 | 1.66%
Institutional Daily Volume
Avg Daily Volume: .38M
Avg Daily Volume (30 D): 1.29M
Avg Daily Volume (90 D): 1.49M
Trade Size
Avg Trade Size (Sh.): 152
Avg Trade Size (Sh.) (30 D): 98
Avg Trade Size (Sh.) (90 D): 96
Institutional Trades
Total Inst.Trades: 1,665
Avg Inst. Trade: $1.55M
Avg Inst. Trade (30 D): $2.4M
Avg Inst. Trade (90 D): $2.21M
Avg Inst. Trade Volume: .18M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.67M
Avg Closing Trade (30 D): $2.76M
Avg Closing Trade (90 D): $2.51M
Avg Closing Volume: 203.26K
   
News
Jun 25, 2025 @ 12:00 PM
Amneal Highlights Positive Topline Results from Co...
Source: N/A
Jun 12, 2025 @ 12:00 PM
Amneal Receives U.S. FDA Approval for Prednisolone...
Source: Amneal Pharmaceuticals, Inc.
Jun 9, 2025 @ 8:56 AM
Selective Estrogen Receptor Modulators Market Rese...
Source: Researchandmarkets.Com
Jun 6, 2025 @ 5:31 PM
Goldman Sachs Bullish On Branded Drug Upside At Te...
Source: Vandana Singh
Jun 5, 2025 @ 5:00 PM
Global Antidote Market to Cross the USD 4 Billion ...
Source: Delveinsight
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-.04 $.04 $-.1
Diluted EPS $-.04 $.04 $-.1
Revenue $ 2.83B $ 695.42M $ 730.52M
Gross Profit $ 1.04B $ 255.89M $ 262.87M
Net Income / Loss $ 32.42M $ 24.62M $ -20.74M
Operating Income / Loss $ 360.42M $ 100.35M $ 75.79M
Cost of Revenue $ 1.79B $ 439.53M $ 467.65M
Net Cash Flow $ 16.78M $ -50.03M $ 40.08M
PE Ratio    
Splits
Aug 26, 2013:   1:25